Shizuo Akira
19Patents
5h-index
29Co-inventors
66Inventor score
Filing activity: Oct 22, 1990 → Jun 22, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8592566B2 | Immunostimulatory oligonucleotides and use thereof in pharmaceuticals | Human Necessities | 17 | Active |
| US5844082A | Human acute phase response factor | Emerging Cross-Sectional Technologies | 14 | Expired |
| US5719042A | Nucleic acids encoding transcription factor APRF (acute phase response factor) | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5215892A | C/EBP2 gene and recombinant C/EBP2 | Chemistry; Metallurgy | 6 | Expired |
| US9498527B2 | Vaccine composition | Emerging Cross-Sectional Technologies | 5 | Active |
| US7507872B2 | Transgenic toll-like receptor 9 (TLR9) mice | Human Necessities | 4 | Expired |
| US7608750B2 | Nonhuman model animal unresponsive to immunopotentiating synthetic compound | Human Necessities | 3 | Expired |
| US8894996B2 | Immunoadjuvant composition and use thereof | Emerging Cross-Sectional Technologies | 3 | Active |
| US5360894A | C/EBP2 gene and recombinant C/EBP2 | Chemistry; Metallurgy | 3 | Expired |
| US5958748A | DNA coding for serine/threonine kinase | Chemistry; Metallurgy | 1 | Expired |
| US7557258B2 | Endotoxin-nonresponsive model animal | Human Necessities | 0 | Expired |
| US7371921B2 | Nonhuman animal model non-responsive to mycoplasma-origin lipoprotein/lipopeptide | Human Necessities | 0 | Expired |
| US9400279B2 | Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction | Emerging Cross-Sectional Technologies | 0 | Active |
| US6171841A | DNA coding for serine/threonine kinase | Chemistry; Metallurgy | 0 | Expired |
| US7078585B1 | Bacterial cell component-unresponsive model mouse | Physics | 0 | Expired |
| US7329795B2 | Model animals non-responsive to mycobacterial-origin lipoprotein/lipopeptide | Human Necessities | 0 | Expired |
| US10172927B2 | Detection/measurement of malaria infection disease utilizing natural immunity by hemozoin induction, screening of preventative or therapeutic medicine for malaria infection disease, and regulation of natural immunity induction | Emerging Cross-Sectional Technologies | 0 | Active |
| US9056094B2 | Adjuvant | Human Necessities | 0 | Active |
| US9732107B2 | Method for producing beta-hematin crystal comprising step of heating | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.